Skip to Main Content
Yale Center for Clinical Investigation
YSM Home

INFORMATION FOR

Diabetes Mellitus - Type 2 | Diseases of the Blood | Diseases of the Digestive System - Liver | Immune System

Semaglutide Effects in Obese Youth With Prediabetes/​New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

What is the purpose of this trial?

The purpose of this study is to understand the role of GLP-1 in the pathogenesis of T2D in youth and explore their potential salutary effects and ability to delay the progressive loss of ß-cell function and reduce hepatic steatosis in youth with prediabetes/new onset T2D and NAFLD.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact YWeight

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Sub-Investigators

  • Last Updated
    04/28/2024
  • Study HIC
    #2000031181

Contact Information

For more information about this study, including how to volunteer, contact YWeight